1 / 1
Tatler+
Galderma redefines acne management with the launch of Trifarotene, a cutting-edge retinoid cream that’s set to elevate acne management across the country
Finding an effective and safe treatment for acne is always a personalised challenge; countless dermatology appointments and numerous trials and errors often happen. So now, as the Philippines embraces the latest advancements in skincare, the introduction of a groundbreaking retinoid molecule for acne treatment is capturing the attention of the nation's beauty and wellness aficionados. Those who struggle with acne will be glad to know that Galderma, a titan in global dermatology, has brought Trifarotene cream to the Philippine market, adding to its esteemed repertoire of innovative skincare solutions by gathering doctors from around the country to introduce this new game-changer.
Acne, the most prevalent skin disease in the Philippines, affects a staggering 17 million individuals across various age groups. This condition, often a source of discomfort and self-consciousness, extends beyond the face and impacts areas such as the chest, shoulders, and back. The social and psychological ramifications are particularly acute among teenagers, for whom acne can deeply affect self-esteem and interpersonal relationships.
Above Image courtesy of Galderma
Image courtesy of Galderma
1 / 1
Trifarotene cream heralds a new era in acne treatment, being the first new retinoid molecule approved by the FDA for this purpose in over two and a half decades. This topical single-agent retinoid cream stands out for its efficacy in treating acne not just on the face but also on the body. Its revolutionary formula works by accelerating skin cell renewal and targeting retinoic acid receptor gamma (RAR-γ), the predominant receptor in the skin. This approach not only diminishes inflammation but also addresses key factors contributing to acne formation.
The release of Trifarotene in the Philippines is a testament to Galderma's commitment to enhancing dermatological care. The company, renowned for its portfolio that includes beloved brands like Cetaphil, Benzac, and Restylane, continues to lead the way in dermatologist-approved skincare innovations. This latest offering is set to change the landscape of acne treatment in the country, providing a safe and effective prescription option for those grappling with this pervasive skin condition.
Above Image courtesy of Galderma
Image courtesy of Galderma
1 / 1
Trifarotene will be available exclusively through licensed healthcare practitioners, primarily dermatologists, and is recommended for patients aged 12 and older. This ensures a professional and tailored approach to acne management, aligning with Galderma's ethos of partnering with healthcare professionals to meet the skin health needs of individuals throughout their lives.
The introduction of Trifarotene by Galderma is more than just a new product launch; it represents a leap forward in dermatological science and patient care in the Philippines. This development not only offers hope to millions suffering from acne but also reinforces Galderma's position as a beacon of innovation in the global skincare arena.
For more information, please visit galderma.com.
About:
Dara is the Branded Content Manager at Tatler Philippines, holding a Bachelor's degree in Entrepreneurship from De La Salle University, Manila.
A self-proclaimed jack of all hobbies, she enjoys music, sports, arts and crafts, and travelling. Outside of work, you can probably find her spending time with her dogs, making jewellery, or relaxing at the beach with family and friends.
Work:
If you have any inquiries or leads, please feel free to contact Dara at dara.evangelista@tatlerasia.com or send her a message on Instagram at @daraclariza.
